Home ➤ Life Science ➤ Diagnostics ➤ Minimal Residual Disease Market
Minimal Residual Disease Market
Published date: March 2025 • Formats:
Request Sample Schedule a Call

Minimal Residual Disease Market By Product Type (Flow Cytometry, Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), and Others), By Technology (Hematological Malignancy and Solid Tumors), By End-user (Hospitals & Specialty Clinics, Academic & Research Institutes, Diagnostic Laboratories, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

  • Published date: March 2025
  • Report ID: 142600
  • Number of Pages: 245
  • Format:
  • keyboard_arrow_up
    • 1. Executive Summary
      • 1.1. Definition
      • 1.2. Market Snapshot
      • 1.3. Market Overview
      • 1.4. Segment Overview
      • 1.5. Regional Overview
      • 1.6. Competitive Landscape
      • 1.7. Taxonomy
    • 2. Global Market Overview
      • 2.1. Global Market Insights and Industry Overview
      • 2.2. Market Dynamics
        • 2.2.1. Drivers
        • 2.2.2. Restraints
        • 2.2.3. Opportunities
        • 2.2.4. Key Minimal Residual Disease Market Trends
      • 2.3. Regulatory Framework
      • 2.4. Opportunity Map Analysis
      • 2.5. Opportunity Orbits
      • 2.6. PESTLE Analysis
      • 2.7. PORTER’S Five Force Analysis
      • 2.8. Drivers & Restraints Impact Analysis
      • 2.9. Value Chain Analysis
        • 2.9.1. List of Raw Materials Suppliers
        • 2.9.2. List of Minimal Residual Disease Manufacturers
        • 2.9.3. List of Dealer/Distributors
      • 2.10. Regional Market Share and BPS Analysis
      • 2.11. Impact of Macro-economic Factors/Geopolitical Factors
    • 3. Global Minimal Residual Disease Market Analysis and Forecast, By Segment, 2020-2034
      • 3.1. Key Findings
      • 3.2. Global Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 3.3. Global Minimal Residual Disease Market Attractiveness Analysis, By Product Type
        • 3.3.1. Flow Cytometry
          • 3.3.1.1. Insights
          • 3.3.1.2. Key Takeaways
        • 3.3.2. Next Generation Sequencing (NGS)
          • 3.3.2.1. Insights
          • 3.3.2.2. Key Takeaways
        • 3.3.3. Polymerase Chain Reaction (PCR)
          • 3.3.3.1. Insights
          • 3.3.3.2. Key Takeaways
        • 3.3.4. Others
          • 3.3.4.1. Insights
          • 3.3.4.2. Key Takeaways
      • 3.4. Global Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 3.5. Global Minimal Residual Disease Market Attractiveness Analysis, By Technology
        • 3.5.1. Hematological Malignancy
          • 3.5.1.1. Insights
          • 3.5.1.2. Key Takeaways
            • 3.5.1.2.1. Lymphoma
            • 3.5.1.2.2. Leukemia
        • 3.5.2. Solid Tumors
          • 3.5.2.1. Insights
          • 3.5.2.2. Key Takeaways
      • 3.6. Global Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 3.7. Global Minimal Residual Disease Market Attractiveness Analysis, By End-user
        • 3.7.1. Hospitals & Specialty Clinics
          • 3.7.1.1. Insights
          • 3.7.1.2. Key Takeaways
        • 3.7.2. Academic & Research Institutes
          • 3.7.2.1. Insights
          • 3.7.2.2. Key Takeaways
        • 3.7.3. Diagnostic Laboratories
          • 3.7.3.1. Insights
          • 3.7.3.2. Key Takeaways
        • 3.7.4. Others
          • 3.7.4.1. Insights
          • 3.7.4.2. Key Takeaways
    • 4. Global Minimal Residual Disease Market Analysis and Forecast, By Region, 2020-2034
      • 4.1. Key Findings
      • 4.2. Global Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
        • 4.2.1. North America
          • 4.2.1.1. Regional Insights
        • 4.2.2. Europe
          • 4.2.2.1. Regional Insights
        • 4.2.3. Asia Pacific
          • 4.2.3.1. Regional Insights
        • 4.2.4. Latin America
          • 4.2.4.1. Regional Insights
        • 4.2.5. Middle East & Africa
          • 4.2.5.1. Regional Insights
      • 4.3. Global Minimal Residual Disease Market Attractiveness Analysis, By Region
    • 5. North America Minimal Residual Disease Market Analysis and Forecast, 2020-2034
      • 5.1. Key Findings
      • 5.2. North America Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 5.3. North America Minimal Residual Disease Market Attractiveness Analysis, By Product Type
      • 5.4. North America Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 5.5. North America Minimal Residual Disease Market Attractiveness Analysis, By Technology
      • 5.6. North America Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 5.7. North America Minimal Residual Disease Market Attractiveness Analysis, By End-user
      • 5.8. North America Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 5.9. North America Minimal Residual Disease Market Attractiveness Analysis, By Country
        • 5.9.1. The US
        • 5.9.2. Canada
    • 6. Europe Minimal Residual Disease Market Analysis and Forecast, 2020-2034
      • 6.1. Key Findings
      • 6.2. Europe Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 6.3. Europe Minimal Residual Disease Market Attractiveness Analysis, By Product Type
      • 6.4. Europe Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 6.5. Europe Minimal Residual Disease Market Attractiveness Analysis, By Technology
      • 6.6. Europe Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 6.7. Europe Minimal Residual Disease Market Attractiveness Analysis, By End-user
      • 6.8. Europe Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 6.9. Europe Minimal Residual Disease Market Attractiveness Analysis, By Country
        • 6.9.1. Germany
        • 6.9.2. The UK
        • 6.9.3. France
        • 6.9.4. Spain
        • 6.9.5. Italy
        • 6.9.6. Russia
        • 6.9.7. Netherland
        • 6.9.8. Rest of Europe
    • 7. Asia Pacific Minimal Residual Disease Market Analysis and Forecast, 2020-2034
      • 7.1. Key Findings
      • 7.2. Asia Pacific Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 7.3. Asia Pacific Minimal Residual Disease Market Attractiveness Analysis, By Product Type
      • 7.4. Asia Pacific Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 7.5. Asia Pacific Minimal Residual Disease Market Attractiveness Analysis, By Technology
      • 7.6. Asia Pacific Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 7.7. Asia Pacific Minimal Residual Disease Market Attractiveness Analysis, By End-user
      • 7.8. Asia Pacific Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 7.9. Asia Pacific Minimal Residual Disease Market Attractiveness Analysis, By Country
        • 7.9.1. China
        • 7.9.2. Japan
        • 7.9.3. South Korea
        • 7.9.4. India
        • 7.9.5. Australia
        • 7.9.6. New Zealand
        • 7.9.7. Singapore
        • 7.9.8. Thailand
        • 7.9.9. Vietnam
        • 7.9.10. Rest of Asia Pacific
    • 8. Latin America Minimal Residual Disease Market Analysis and Forecast, 2020-2034
      • 8.1. Key Findings
      • 8.2. Latin America Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 8.3. Latin America Minimal Residual Disease Market Attractiveness Analysis, By Product Type
      • 8.4. Latin America Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 8.5. Latin America Minimal Residual Disease Market Attractiveness Analysis, By Technology
      • 8.6. Latin America Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 8.7. Latin America Minimal Residual Disease Market Attractiveness Analysis, By End-user
      • 8.8. Latin America Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 8.9. Latin America Minimal Residual Disease Market Attractiveness Analysis, By Country
        • 8.9.1. Brazil
        • 8.9.2. Mexico
        • 8.9.3. Rest of Latin America
    • 9. Middle East & Africa Minimal Residual Disease Market Analysis and Forecast, 2020-2034
      • 9.1. Key Findings
      • 9.2. Middle East & Africa Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 9.3. Middle East & Africa Minimal Residual Disease Market Attractiveness Analysis, By Product Type
      • 9.4. Middle East & Africa Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 9.5. Middle East & Africa Minimal Residual Disease Market Attractiveness Analysis, By Technology
      • 9.6. Middle East & Africa Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 9.7. Middle East & Africa Minimal Residual Disease Market Attractiveness Analysis, By End-user
      • 9.8. Middle East & Africa Minimal Residual Disease Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 9.9. Middle East & Africa Minimal Residual Disease Market Attractiveness Analysis, By Country
        • 9.9.1. South Africa
        • 9.9.2. Saudi Arabia
        • 9.9.3. UAE
        • 9.9.4. Rest of Middle East & Africa
    • 10. Competitive Landscape & Company Profiles
      • 10.1. Market Competition Scenario Analysis, By Company
        • 10.1.1. Key Takeaways
      • 10.2. Overview of Major Market Players
      • 10.3. Competitor Landscape
      • 10.4. Strategic Mapping
      • 10.5. Company Life Cycle Analysis
      • 10.6. Company Market Share Analysis
      • 10.7. Company Profiles
        • 10.7.1. QIAGEN
          • 10.7.1.1. Company Details
          • 10.7.1.2. Business Overview
          • 10.7.1.3. Product Portfolio
          • 10.7.1.4. Financial Insights
          • 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.1.6. SWOT Analysis
          • 10.7.1.7. Geographic Footprint
        • 10.7.2. Personalis
          • 10.7.2.1. Company Details
          • 10.7.2.2. Business Overview
          • 10.7.2.3. Product Portfolio
          • 10.7.2.4. Financial Insights
          • 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.2.6. SWOT Analysis
          • 10.7.2.7. Geographic Footprint
        • 10.7.3. Invitae
          • 10.7.3.1. Company Details
          • 10.7.3.2. Business Overview
          • 10.7.3.3. Product Portfolio
          • 10.7.3.4. Financial Insights
          • 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.3.6. SWOT Analysis
          • 10.7.3.7. Geographic Footprint
        • 10.7.4. Guardant Health
          • 10.7.4.1. Company Details
          • 10.7.4.2. Business Overview
          • 10.7.4.3. Product Portfolio
          • 10.7.4.4. Financial Insights
          • 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.4.6. SWOT Analysis
          • 10.7.4.7. Geographic Footprint
        • 10.7.5. GRAIL, LLC
          • 10.7.5.1. Company Details
          • 10.7.5.2. Business Overview
          • 10.7.5.3. Product Portfolio
          • 10.7.5.4. Financial Insights
          • 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.5.6. SWOT Analysis
          • 10.7.5.7. Geographic Footprint
        • 10.7.6. FOUNDATION MEDICINE, INC
          • 10.7.6.1. Company Details
          • 10.7.6.2. Business Overview
          • 10.7.6.3. Product Portfolio
          • 10.7.6.4. Financial Insights
          • 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.6.6. SWOT Analysis
          • 10.7.6.7. Geographic Footprint
        • 10.7.7. F. Hoffmann-La Roche Ltd
          • 10.7.7.1. Company Details
          • 10.7.7.2. Business Overview
          • 10.7.7.3. Product Portfolio
          • 10.7.7.4. Financial Insights
          • 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.7.6. SWOT Analysis
          • 10.7.7.7. Geographic Footprint
        • 10.7.8. Exact Sciences Corporation
          • 10.7.8.1. Company Details
          • 10.7.8.2. Business Overview
          • 10.7.8.3. Product Portfolio
          • 10.7.8.4. Financial Insights
          • 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.8.6. SWOT Analysis
          • 10.7.8.7. Geographic Footprint
    • 11. Methodology and Data Source
      • 11.1. Methodology/Research Approach
      • 11.2. Market Size Estimation
      • 11.3. Market Breakdown and Data Triangulation
      • 11.4. Data Source
      • 11.5. Secondary Sources
      • 11.6. Primary Sources
      • 11.7. Appendix
      • 11.8. Disclaimer
    • List of Tables
      • Table 1. Global Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 2. Global Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 3. Global Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 4. Global Minimal Residual Disease Market Value (US$ Mn), By Region, 2020-2034
      • Table 5. North America Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 6. North America Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 7. North America Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 8. North America Minimal Residual Disease Market Value (US$ Mn), By Country, 2020-2034
      • Table 9. The US Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 10. The US Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 11. The US Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 12. Canada Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 13. Canada Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 14. Canada Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 15. Europe Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 16. Europe Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 17. Europe Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 18. Europe Minimal Residual Disease Market Value (US$ Mn), By Country, 2020-2034
      • Table 19. Germany Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 20. Germany Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 21. Germany Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 22. The UK Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 23. The UK Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 24. The UK Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 25. France Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 26. France Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 27. France Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 28. Spain Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 29. Spain Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 30. Spain Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 31. Italy Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 32. Italy Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 33. Italy Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 34. Russia Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 35. Russia Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 36. Russia Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 37. Netherland Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 38. Netherland Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 39. Netherland Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 40. Rest of Europe Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 41. Rest of Europe Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 42. Rest of Europe Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 43. Asia Pacific Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 44. Asia Pacific Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 45. Asia Pacific Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 46. Asia Pacific Minimal Residual Disease Market Value (US$ Mn), By Country, 2020-2034
      • Table 47. China Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 48. China Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 49. China Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 50. India Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 51. India Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 52. India Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 53. Japan Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 54. Japan Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 55. Japan Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 56. South Korea Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 57. South Korea Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 58. South Korea Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 59. Australia Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 60. Australia Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 61. Australia Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 62. New Zealand Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 63. New Zealand Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 64. New Zealand Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 65. Singapore Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 66. Singapore Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 67. Singapore Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 68. Thailand Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 69. Thailand Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 70. Thailand Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 71. Vietnam Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 72. Vietnam Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 73. Vietnam Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 74. Rest of Asia Pacific Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 75. Rest of Asia Pacific Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 76. Rest of Asia Pacific Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 77. Latin America Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 78. Latin America Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 79. Latin America Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 80. Latin America Minimal Residual Disease Market Value (US$ Mn), By Country, 2020-2034
      • Table 81. Brazil Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 82. Brazil Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 83. Brazil Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 84. Mexico Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 85. Mexico Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 86. Mexico Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 87. Rest of Latin America Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 88. Rest of Latin America Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 89. Rest of Latin America Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 90. Middle East & Africa Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 91. Middle East & Africa Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 92. Middle East & Africa Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 93. Middle East & Africa Minimal Residual Disease Market Value (US$ Mn), By Country, 2020-2034
      • Table 94. South Africa Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 95. South Africa Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 96. South Africa Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 97. Saudi Arabia Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 98. Saudi Arabia Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 99. Saudi Arabia Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 100. UAE Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 101. UAE Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 102. UAE Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
      • Table 103. Rest of Middle East & Africa Minimal Residual Disease Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 104. Rest of Middle East & Africa Minimal Residual Disease Market Value (US$ Mn), By Technology, 2020-2034
      • Table 105. Rest of Middle East & Africa Minimal Residual Disease Market Value (US$ Mn), By End-user, 2020-2034
    • List of Figures
      • Figure 1. Global Minimal Residual Disease Market Snapshot: Market Value (US$ Mn), 2020-2034
      • Figure 2. Opportunity Map
      • Figure 3. Opportunity Orbit
      • Figure 4. Regional Market Share and BPS Analysis in Minimal Residual Disease Market
      • Figure 5. Global Minimal Residual Disease Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 6. Global Minimal Residual Disease Market Attractiveness Analysis, By Product Type
      • Figure 7. Global Minimal Residual Disease Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 8. Global Minimal Residual Disease Market Attractiveness Analysis, By Technology
      • Figure 9. Global Minimal Residual Disease Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 10. Global Minimal Residual Disease Market Attractiveness Analysis, By End-user
      • Figure 11. Global Minimal Residual Disease Market Analysis, By Region, 2020, 2024 and 2034
      • Figure 12. Global Minimal Residual Disease Market Attractiveness Analysis, By Region
      • Figure 13. North America Minimal Residual Disease Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 14. North America Minimal Residual Disease Market Attractiveness Analysis, By Product Type
      • Figure 15. North America Minimal Residual Disease Market (US$ Mn), by Flow Cytometry, 2020-2034
      • Figure 16. North America Minimal Residual Disease Market (US$ Mn), by Next Generation Sequencing (NGS), 2020-2034
      • Figure 17. North America Minimal Residual Disease Market (US$ Mn), by Polymerase Chain Reaction (PCR), 2020-2034
      • Figure 18. North America Minimal Residual Disease Market (US$ Mn), by Others, 2020-2034
      • Figure 19. North America Minimal Residual Disease Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 20. North America Minimal Residual Disease Market Attractiveness Analysis, By Technology
      • Figure 21. North America Minimal Residual Disease Market (US$ Mn), by Hematological Malignancy, 2020-2034
      • Figure 22. North America Minimal Residual Disease Market (US$ Mn), by Solid Tumors, 2020-2034
      • Figure 23. North America Minimal Residual Disease Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 24. North America Minimal Residual Disease Market Attractiveness Analysis, By End-user
      • Figure 25. North America Minimal Residual Disease Market (US$ Mn), by Hospitals & Specialty Clinics, 2020-2034
      • Figure 26. North America Minimal Residual Disease Market (US$ Mn), by Academic & Research Institutes, 2020-2034
      • Figure 27. North America Minimal Residual Disease Market (US$ Mn), by Diagnostic Laboratories, 2020-2034
      • Figure 28. North America Minimal Residual Disease Market (US$ Mn), by Others, 2020-2034
      • Figure 29. North America Minimal Residual Disease Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 30. North America Minimal Residual Disease Market Attractiveness Analysis, By Country
      • Figure 31. Europe Minimal Residual Disease Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 32. Europe Minimal Residual Disease Market Attractiveness Analysis, By Product Type
      • Figure 33. Europe Minimal Residual Disease Market (US$ Mn), by Flow Cytometry, 2020-2034
      • Figure 34. Europe Minimal Residual Disease Market (US$ Mn), by Next Generation Sequencing (NGS), 2020-2034
      • Figure 35. Europe Minimal Residual Disease Market (US$ Mn), by Polymerase Chain Reaction (PCR), 2020-2034
      • Figure 36. Europe Minimal Residual Disease Market (US$ Mn), by Others, 2020-2034
      • Figure 37. Europe Minimal Residual Disease Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 38. Europe Minimal Residual Disease Market Attractiveness Analysis, By Technology
      • Figure 39. Europe Minimal Residual Disease Market (US$ Mn), by Hematological Malignancy, 2020-2034
      • Figure 40. Europe Minimal Residual Disease Market (US$ Mn), by Solid Tumors, 2020-2034
      • Figure 41. Europe Minimal Residual Disease Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 42. Europe Minimal Residual Disease Market Attractiveness Analysis, By End-user
      • Figure 43. Europe Minimal Residual Disease Market (US$ Mn), by Hospitals & Specialty Clinics, 2020-2034
      • Figure 44. Europe Minimal Residual Disease Market (US$ Mn), by Academic & Research Institutes, 2020-2034
      • Figure 45. Europe Minimal Residual Disease Market (US$ Mn), by Diagnostic Laboratories, 2020-2034
      • Figure 46. Europe Minimal Residual Disease Market (US$ Mn), by Others, 2020-2034
      • Figure 47. Europe Minimal Residual Disease Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 48. Europe Minimal Residual Disease Market Attractiveness Analysis, By Country
      • Figure 49. Asia Pacific Minimal Residual Disease Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 50. Asia Pacific Minimal Residual Disease Market Attractiveness Analysis, By Product Type
      • Figure 51. Asia Pacific Minimal Residual Disease Market (US$ Mn), by Flow Cytometry, 2020-2034
      • Figure 52. Asia Pacific Minimal Residual Disease Market (US$ Mn), by Next Generation Sequencing (NGS), 2020-2034
      • Figure 53. Asia Pacific Minimal Residual Disease Market (US$ Mn), by Polymerase Chain Reaction (PCR), 2020-2034
      • Figure 54. Asia Pacific Minimal Residual Disease Market (US$ Mn), by Others, 2020-2034
      • Figure 55. Asia Pacific Minimal Residual Disease Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 56. Asia Pacific Minimal Residual Disease Market Attractiveness Analysis, By Technology
      • Figure 57. Asia Pacific Minimal Residual Disease Market (US$ Mn), by Hematological Malignancy, 2020-2034
      • Figure 58. Asia Pacific Minimal Residual Disease Market (US$ Mn), by Solid Tumors, 2020-2034
      • Figure 59. Asia Pacific Minimal Residual Disease Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 60. Asia Pacific Minimal Residual Disease Market Attractiveness Analysis, By End-user
      • Figure 61. Asia Pacific Minimal Residual Disease Market (US$ Mn), by Hospitals & Specialty Clinics, 2020-2034
      • Figure 62. Asia Pacific Minimal Residual Disease Market (US$ Mn), by Academic & Research Institutes, 2020-2034
      • Figure 63. Asia Pacific Minimal Residual Disease Market (US$ Mn), by Diagnostic Laboratories, 2020-2034
      • Figure 64. Asia Pacific Minimal Residual Disease Market (US$ Mn), by Others, 2020-2034
      • Figure 65. Asia Pacific Minimal Residual Disease Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 66. Asia Pacific Minimal Residual Disease Market Attractiveness Analysis, By Country
      • Figure 67. Latin America Minimal Residual Disease Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 68. Latin America Minimal Residual Disease Market Attractiveness Analysis, By Product Type
      • Figure 69. Latin America Minimal Residual Disease Market (US$ Mn), by Flow Cytometry, 2020-2034
      • Figure 70. Latin America Minimal Residual Disease Market (US$ Mn), by Next Generation Sequencing (NGS), 2020-2034
      • Figure 71. Latin America Minimal Residual Disease Market (US$ Mn), by Polymerase Chain Reaction (PCR), 2020-2034
      • Figure 72. Latin America Minimal Residual Disease Market (US$ Mn), by Others, 2020-2034
      • Figure 73. Latin America Minimal Residual Disease Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 74. Latin America Minimal Residual Disease Market Attractiveness Analysis, By Technology
      • Figure 75. Latin America Minimal Residual Disease Market (US$ Mn), by Hematological Malignancy, 2020-2034
      • Figure 76. Latin America Minimal Residual Disease Market (US$ Mn), by Solid Tumors, 2020-2034
      • Figure 77. Latin America Minimal Residual Disease Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 78. Latin America Minimal Residual Disease Market Attractiveness Analysis, By End-user
      • Figure 79. Latin America Minimal Residual Disease Market (US$ Mn), by Hospitals & Specialty Clinics, 2020-2034
      • Figure 80. Latin America Minimal Residual Disease Market (US$ Mn), by Academic & Research Institutes, 2020-2034
      • Figure 81. Latin America Minimal Residual Disease Market (US$ Mn), by Diagnostic Laboratories, 2020-2034
      • Figure 82. Latin America Minimal Residual Disease Market (US$ Mn), by Others, 2020-2034
      • Figure 83. Latin America Minimal Residual Disease Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 84. Latin America Minimal Residual Disease Market Attractiveness Analysis, By Country
      • Figure 85. Middle East & Africa Minimal Residual Disease Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 86. Middle East & Africa Minimal Residual Disease Market Attractiveness Analysis, By Product Type
      • Figure 87. Middle East & Africa Minimal Residual Disease Market (US$ Mn), by Flow Cytometry, 2020-2034
      • Figure 88. Middle East & Africa Minimal Residual Disease Market (US$ Mn), by Next Generation Sequencing (NGS), 2020-2034
      • Figure 89. Middle East & Africa Minimal Residual Disease Market (US$ Mn), by Polymerase Chain Reaction (PCR), 2020-2034
      • Figure 90. Middle East & Africa Minimal Residual Disease Market (US$ Mn), by Others, 2020-2034
      • Figure 91. Middle East & Africa Minimal Residual Disease Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 92. Middle East & Africa Minimal Residual Disease Market Attractiveness Analysis, By Technology
      • Figure 93. Middle East & Africa Minimal Residual Disease Market (US$ Mn), by Hematological Malignancy, 2020-2034
      • Figure 94. Middle East & Africa Minimal Residual Disease Market (US$ Mn), by Solid Tumors, 2020-2034
      • Figure 95. Middle East & Africa Minimal Residual Disease Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 96. Middle East & Africa Minimal Residual Disease Market Attractiveness Analysis, By End-user
      • Figure 97. Middle East & Africa Minimal Residual Disease Market (US$ Mn), by Hospitals & Specialty Clinics, 2020-2034
      • Figure 98. Middle East & Africa Minimal Residual Disease Market (US$ Mn), by Academic & Research Institutes, 2020-2034
      • Figure 99. Middle East & Africa Minimal Residual Disease Market (US$ Mn), by Diagnostic Laboratories, 2020-2034
      • Figure 100. Middle East & Africa Minimal Residual Disease Market (US$ Mn), by Others, 2020-2034
      • Figure 101. Middle East & Africa Minimal Residual Disease Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 102. Middle East & Africa Minimal Residual Disease Market Attractiveness Analysis, By Country
    • QIAGEN NV Company Profile
    • Personalis
    • Invitae
    • Guardant Health
    • GRAIL, LLC
    • FOUNDATION MEDICINE, INC
    • Hoffmann-La Roche Ltd
    • Exact Sciences Corporation
  • settingsSettings

Related Reports

Our Clients

  • Our Clients
Inquiry Before Buying

Minimal Residual Disease Market
  • 142600
  • March 2025
    • ★★★★★
      ★★★★★
    • (142)
add_shopping_cart Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$6,000
$3,999
USD / per unit
save 24%
Multi User
$8,000
$5,999
USD / per unit
save 28%
Corporate User
$10,000
$6,999
USD / per unit
save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 3,999) Buy Now ($ 5,999) Buy Now ($ 6,999)
Find Help
Legal
Explore
Secured Payment Options
Secured Payment Options